James L. Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
James L. Chen has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Yves Andre Lussier
University of Utah
2 shared publications - H. Rosie Xing
Department of Pathology & Radiation Oncology, University of Chicago, Chicago, IL, USA
1 shared publication - Xinan Holly Yang
Departments of Pediatrics, Pathology, and Human Genetics, The University of Chicago, Chicago, IL 60637, USA
1 shared publication - Yong Huang
Department of Medicine, Knapp Center for Biomedical Discovery, University of Chicago, Chicago, Illinois; †Argonne National Laboratory, Argonne, Illinois; ‡Department of Medicine, Mayo Clinic, Rochester, Minnesota; and §Biosciences Division, Josephine Bay Paul Center, Marine Biological Laboratory at Woods Hole, Woods Hole, Massachusetts
1 shared publication - Younghee Lee
Ctr for Biom. Info. Section of Genetic Medicine, Dept. of Medicine, U. of Chicago, IL, USA
1 shared publication
Latest Publications
- 17 August 2011
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 3 (96) , 96ps35
The Emergence of Genome-Based Drug Repositioning
Genome-wide methods of mRNA signature analyses permit the high-throughput evaluation of medications for drug repurposing.
- 17 August 2011
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 3 (96) , 96ps35
The Emergence of Genome-Based Drug Repositioning
Genome-wide methods of mRNA signature analyses permit the high-throughput evaluation of medications for drug repurposing.
- Open Access
- 28 October 2010
- Published by Springer Nature in BMC Bioinformatics
- Vol. 11 (S9) , S11
Stromal microenvironment processes unveiled by biological component analysis of gene expression in xenograft tumor models
Background: Mouse xenograft models, in which human cancer cells are implanted in immune-suppressed mice, have been popular for studying the mechanisms of novel therapeutic targets, tumor progression and metastasis. We hypothesized that we could exploit the interspecies genetic differences in these experiments. Our purpose is to elucidate stromal microenvironment signals from probes on human arrays unintentionally cross-hybridizing with mouse homologous genes in xenograft tumor models. Results: By identifying cross-species hybridizing probes from sequence alignment and cross-species hybridization experiment for the human whole-genome arrays, deregulated stromal genes can be identified and then their biological significance were predicted from enrichment studies. Comparing these results with those found by the laser capture microdissection of stromal cells from tumor specimens resulted in the discovery of significantly enriched stromal biological processes. Conclusions: Using this method, in addition to their primary endpoints, researchers can leverage xenograft experiments to better characterize the tumor microenvironment without additional costs. The Xhyb probes and R script are available at http://www.lussierlab.org/publications/Stroma
- 28 October 2010
- Published by Springer Nature in BMC Bioinformatics
- Vol. 11 (S9) , S11
Open AccessStromal microenvironment processes unveiled by biological component analysis of gene expression in xenograft tumor models
Background: Mouse xenograft models, in which human cancer cells are implanted in immune-suppressed mice, have been popular for studying the mechanisms of novel therapeutic targets, tumor progression and metastasis. We hypothesized that we could exploit the interspecies genetic differences in these experiments. Our purpose is to elucidate stromal microenvironment signals from probes on human arrays unintentionally cross-hybridizing with mouse homologous genes in xenograft tumor models. Results: By identifying cross-species hybridizing probes from sequence alignment and cross-species hybridization experiment for the human whole-genome arrays, deregulated stromal genes can be identified and then their biological significance were predicted from enrichment studies. Comparing these results with those found by the laser capture microdissection of stromal cells from tumor specimens resulted in the discovery of significantly enriched stromal biological processes. Conclusions: Using this method, in addition to their primary endpoints, researchers can leverage xenograft experiments to better characterize the tumor microenvironment without additional costs. The Xhyb probes and R script are available at http://www.lussierlab.org/publications/Stroma